Activated glucocorticoid and eicosanoid pathways in endometriosis

Area of Science:

• Reproductive biology
• Molecular endocrinology
• Genomics

Background:

• Endometriosis is a complex gynecological condition characterized by endometrial-like tissue outside the uterus.
• Altered gene expression networks are implicated in the pathophysiology of endometriosis.
• Understanding these networks is crucial for developing targeted therapies.

Purpose of the Study:

• To define the altered gene expression networks in endometriosis.
• To investigate the role of glucocorticoids and prostaglandins in endometriosis.
• To identify key molecular pathways contributing to the disease.

Main Methods:

• Genome-wide gene expression analysis using microarrays on matched endometriotic and eutopic endometrial tissues.
• Verification of differentially expressed genes in a separate cohort.
• Functional studies in primary endometriotic stromal cells to elucidate signaling pathways.

Main Results:

• Identified 1,366 differentially expressed genes, revealing a network favoring increased glucocorticoid levels and action.
• Found significantly higher transcript and protein levels of 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) and glucocorticoid receptor in endometriosis.
• Observed significantly lower levels of the cortisol-degrading enzyme HSD11B2 in endometriotic tissues.
• Demonstrated that tumor necrosis factor stimulates cortisol production and action while suppressing cortisol degradation in endometriotic stromal cells.
• Uncovered a subset of genes critical for prostaglandin synthesis and degradation, leading to elevated eicosanoid levels.

Conclusions:

• The proinflammatory environment of endometriotic lesions stimulates local cortisol synthesis and action.
• Dysregulated glucocorticoid metabolism and signaling contribute to the pathogenesis of endometriosis.
• Aberrant prostaglandin pathways are also implicated in endometriosis, promoting high eicosanoid activity.